Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Refractory Urge Incontinence and Botox Injections.

Trial Profile

Refractory Urge Incontinence and Botox Injections.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2011

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Overactive bladder; Urge incontinence
  • Focus Therapeutic Use
  • Acronyms RUBI
  • Most Recent Events

    • 10 Jan 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov. (NCT00373789)
    • 20 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Aug 2007 Interim results have been reported at the ICS 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top